Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

Bibliographic Details
Main Authors:	Bedognetti, Davide, Wang, Ena, Marincola, Francesco M
Format:	Online
Language:	English
Published:	Landes Bioscience 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203509/

Similar Items

Prognostic signatures of breast cancer: Perou's molecular subtypes and Schmidt's metagenes
by: Cadenas, Cristina
Published: (2012)

Biomolecular Events in Cancer Revealed by Attractor Metagenes
by: Cheng, Wei-Yi, et al.
Published: (2013)

Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response
by: Li, Qiyuan, et al.
Published: (2011)

Metagenes Associated with Survival in Non-Small Cell Lung Cancer
by: Urgard, Egon, et al.
Published: (2011)

MetaGene: prokaryotic gene finding from environmental genome shotgun sequences
by: Noguchi, Hideki, et al.
Published: (2006)

metagene Profiles Analyses Reveal Regulatory Element’s Factor-Specific Recruitment Patterns
by: Joly Beauparlant, Charles, et al.
Published: (2016)

Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
by: Alistar, Angela, et al.
Published: (2014)

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer
by: Miller, Lance D, et al.
Published: (2014)

Toward the identification of genetic determinants of breast cancer immune responsiveness
by: Simeone, Ines, et al.
Published: (2015)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
by: Wang, Cuini, et al.
Published: (2016)

Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis
by: Weiss, Julia Miriam, et al.
Published: (2016)

CXCL13 antibody for the treatment of autoimmune disorders
by: Klimatcheva, Ekaterina, et al.
Published: (2015)

Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy with Listeria monocytogenes
by: Guirnalda, Patrick, et al.
Published: (2013)

Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis
by: De Giorgi, Valeria, et al.
Published: (2013)

Genome-Wide Mutational Signature of the Chemotherapeutic Agent Mitomycin C in Caenorhabditis elegans
by: Tam, Annie S., et al.
Published: (2015)

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus
by: Ascierto, Maria Libera, et al.
Published: (2015)

The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
by: Wang, Ena, et al.
Published: (2012)

CROPPER: a metagene creator resource for cross-platform and cross-species compendium studies
by: Paananen, Jussi, et al.
Published: (2006)

Identification of metagenes and their Interactions through Large-scale Analysis of Arabidopsis Gene Expression Data
by: Wilson, Tyler J, et al.
Published: (2012)

Prediction of Breast Cancer Metastasis by Gene Expression Profiles: A Comparison of Metagenes and Single Genes
by: Burton, Mark, et al.
Published: (2012)

MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN
by: HE, WENWU, et al.
Published: (2012)

Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis
by: Li, Xiaojin, et al.
Published: (2015)

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
by: Gowda, Madhu, et al.
Published: (2011)

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
by: Ascierto, Maria Libera, et al.
Published: (2013)

Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still’s disease
by: Han, Jae Ho, et al.
Published: (2015)

Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study
by: M. M. Remy, et al.
Published: (2017-08-01)

CXCL13, CCL4, and sTNFR as circulating inflammatory cytokine markers in primary and SLE-related autoimmune hemolytic anemia
by: Wu, Boting, et al.
Published: (2015)

Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies
by: Proost, Paul, et al.
Published: (2006)

Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma.
by: Evans, T. R., et al.
Published: (1994)

Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
by: Böger, Christine, et al.
Published: (2015)

IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
by: Maruoka, Hayato, et al.
Published: (2013)

Reflections upon human cancer immune responsiveness to T cell-based therapy
by: Wang, Ena, et al.
Published: (2012)

A genetic inference on cancer immune responsiveness
by: Wang, Ena, et al.
Published: (2012)

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
by: Kowarik, Markus C, et al.
Published: (2012)

CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings
by: Borde, Johannes P, et al.
Published: (2012)

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
by: Bremell, Daniel, et al.
Published: (2013)

LPA Promotes T Cell Recruitment through Synthesis of CXCL13
by: Hui, Weili, et al.
Published: (2015)

CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE
by: Da, Zhanyun, et al.
Published: (2016)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Olsson, Karen M., et al.
Published: (2016)

The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis
by: Dersch, R, et al.
Published: (2015)